FDA Adverse Event Malfunction Summary report: N

BD INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE

MDR report key: 14836366 · Received June 27, 2022

Report

Report Number
1920898-2022-00415
Event Type
Malfunction
Date Received
June 27, 2022
Date of Event
May 29, 2022
Report Date
July 1, 2022
Manufacturer
BD MEDICAL - DIABETES CARE
Product Code
FMF
UDI-DI
00382908468039
PMA / PMN Number
K190054
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NV, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE CORRECTED: D9: DEVICE AVAILABLE FOR EVAL NO, D9: RETURNED TO MANUFACTURER ON: NA. H6: INVESTIGATION SUMMARY NO SAMPLES WERE RETURNED THEREFORE THE INVESTIGATION WAS PERFORMED BASED ON THE PHOTOS PROVIDED. FIVE PHOTOS OF A SHELF CARTON FOR BD INSULINS SYRINGES FROM LOT# 2020067 WERE PROVIDED. THE CUSTOMER REPORTED THAT THE SYRINGES ARE HARD TO PRESS, WOULD LEAK AND CAUSE MISCALCULATION OF DOSE. THE PHOTOS WERE EXAMINED, AND IT WAS OBSERVED THAT NO SYRINGES WERE SHOWN ¿ ONLY THE SHELF CARTON PACKAGING WAS CAPTURED. THE ALLEGED DEFECTS COULD NOT BE CONFIRMED BASED ON THE PHOTOS PROVIDED. A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED FOR BATCH# 2020067. ALL INSPECTIONS AND CHALLENGES WERE PERFORMED PER THE APPLICABLE OPERATIONS QC SPECIFICATIONS. THERE WAS ONE (1) NOTIFICATION NOTED THAT DID NOT PERTAIN TO THE COMPLAINT. EMBECTA WAS NOT ABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE BASED ON THE PHOTOS RECEIVED. ROOT CAUSE CANNOT BE DETERMINED AT THIS TIME AS THE ISSUE IS UNCONFIRMED. H3 OTHER TEXT : SEE H10.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BD INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE ARE DIFFICULT TO MOVE WHICH RESULTS IN LEAKAGE AND MISS CALCULATION OF DOSAGE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: THE SYRINGES ARE DIFFICULT TO MOVE WHICH RESULTS IN LEAKAGE AND MISS CALCULATION OF DOSAGE. COMPLAINED THAT THE SYRINGES ARE VERY HARD TO PRESS AND WHEN PRESSED THE SYRINGE WILL LEAK RESULTING IN MISS CALCULATION OF DOSAGE. REGISTERED NURSE - NO IMPACT TO PATIENT CUSTOMER COMPLAINT ABOUT LEAKAGE AND EASE OF USE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BD INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE ARE DIFFICULT TO MOVE WHICH RESULTS IN LEAKAGE AND MISS CALCULATION OF DOSAGE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: THE SYRINGES ARE DIFFICULT TO MOVE WHICH RESULTS IN LEAKAGE AND MISS CALCULATION OF DOSAGE. COMPLAINED THAT THE SYRINGES ARE VERY HARD TO PRESS AND WHEN PRESSED THE SYRINGE WILL LEAK RESULTING IN MISS CALCULATION OF DOSAGE. REGISTERED NURSE - NO IMPACT TO PATIENT CUSTOMER COMPLAINT ABOUT LEAKAGE AND EASE OF USE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
734907 BD INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE PISTON SYRINGE FMF BD MEDICAL - DIABETES CARE 328468 2020067 00382908468039

Patients

Seq Age Sex Outcome Treatment
1 Unknown